Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Pediatric Health Care: An Introduction

Author(s):  Williams LaVonn A

Issue:  Jan/Feb 2013 - Volume 17, Number 1
View All Articles in Issue

Page(s):  6-8

Pediatric Health Care: An Introduction Page 1
Pediatric Health Care: An Introduction Page 2
Pediatric Health Care: An Introduction Page 3

Download in electronic PDF format for $75

Abstract:  Pediatric healthcare, to include compounded medications, is achallenge for healthcare providers. Although current studies have provided important new informationabout drug safety and effectiveness for children, carrying outstudies in children is difficult. Age-appropriate equipment and medical techniques, along with specialists who are sensitive to a child’s concerns, are a must. Therefore, experts must build a foundationand resources that are needed to conduct studies involving pediatric patients. Compounding pharmacists welcome reliable data from which to use when compounding medications for such an elite group of patients.

Related Keywords: children, child, infants, drug safety, dosages, off-label medication use, loratidine, fentanyl, fluvoxamine maleate, midazolam hydrochloride, gabapentin, famotidine, sevoflurane, United States Food and Drug Administration, FDA

Related Categories: LEGAL, PEDIATRICS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Pediatric Health Care: An Introduction
Williams LaVonn A
Jan/Feb 2013
Pg. 6-8

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Pediatric Compounding: Coloring Outside the Lines
Preckshot John
Jan/Feb 2001
Pg. 6-8

Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)
Allen Loyd V Jr
Sep/Oct 2006
Pg. 390

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P
, Taylor-Zapata Perdita, Mattison Donald
May/Jun 2007
Pg. 220-225

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris
, Greeson Nicole MH, Mixon William
Nov/Dec 2020
Pg. 451-458

Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children
Nahata Milap C
May/Jun 2016
Pg. 247-249

Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Martin Matt
Sep/Oct 2018
Pg. 401-404

Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
Jan/Feb 2020
Pg. 30-36

Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
Sep/Oct 2017
Pg. 364-370

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Medications Discontinued in the United States
Ashworth Lisa D
Jul/Aug 2002
Pg. 286-287

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
Sep/Oct 2018
Pg. 358-366

The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
Jan/Feb 2023
Pg. 22-23

Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
Nov/Dec 2023
Pg. 474-481

Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Kelley Brian
Mar/Apr 2021
Pg. 115-124

Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Greeson Nicole MH
, Mixon William, Allan W Chris
Sep/Oct 2020
Pg. 371-379

Return to Top